[go: up one dir, main page]

ES2361808B8 - Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. - Google Patents

Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. Download PDF

Info

Publication number
ES2361808B8
ES2361808B8 ES200930203A ES200930203A ES2361808B8 ES 2361808 B8 ES2361808 B8 ES 2361808B8 ES 200930203 A ES200930203 A ES 200930203A ES 200930203 A ES200930203 A ES 200930203A ES 2361808 B8 ES2361808 B8 ES 2361808B8
Authority
ES
Spain
Prior art keywords
diagnosis
useful data
obtaining useful
forecast
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200930203A
Other languages
English (en)
Other versions
ES2361808B1 (es
ES2361808A1 (es
Inventor
Jose Ignacio Casal Alvarez
Rodrigo Barderas Manchado
Ingrid Babel Henziett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Centro Nacional de Investigaciones Oncologicas CNIO
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Centro Nacional de Investigaciones Oncologicas CNIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200930203A priority Critical patent/ES2361808B8/es
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Centro Nacional de Investigaciones Oncologicas CNIO filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to AU2010252907A priority patent/AU2010252907B2/en
Priority to ES10730815.7T priority patent/ES2551713T3/es
Priority to PCT/ES2010/070350 priority patent/WO2010136629A1/es
Priority to EP10730815.7A priority patent/EP2444811B1/en
Priority to CA2763557A priority patent/CA2763557C/en
Priority to PL10730815T priority patent/PL2444811T3/pl
Priority to US13/322,303 priority patent/US20120101003A1/en
Publication of ES2361808A1 publication Critical patent/ES2361808A1/es
Publication of ES2361808B1 publication Critical patent/ES2361808B1/es
Application granted granted Critical
Publication of ES2361808B8 publication Critical patent/ES2361808B8/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.#La presente invención se encuadra dentro del campo de la biomedicina. Específicamente, se refiere a un método de obtención de datos útiles para el diagnóstico, el pronóstico o la monitorización de la evolución de un cáncer colorrectal (CCR), a un método de diagnóstico de un CCR, a un método de pronóstico de un CCR ya un kit para llevar a cabo dichos métodos.
ES200930203A 2009-05-25 2009-05-25 Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. Expired - Fee Related ES2361808B8 (es)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ES200930203A ES2361808B8 (es) 2009-05-25 2009-05-25 Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.
ES10730815.7T ES2551713T3 (es) 2009-05-25 2010-05-25 Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal
PCT/ES2010/070350 WO2010136629A1 (es) 2009-05-25 2010-05-25 Métodos para el diagnóstico o pronóstico del cáncer colorrectal
EP10730815.7A EP2444811B1 (en) 2009-05-25 2010-05-25 Methods for the diagnosis or prognosis of colorectal cancer
AU2010252907A AU2010252907B2 (en) 2009-05-25 2010-05-25 Methods for the diagnosis or prognosis of colorectal cancer
CA2763557A CA2763557C (en) 2009-05-25 2010-05-25 Methods for the diagnosis or prognosis of colorectal cancer
PL10730815T PL2444811T3 (pl) 2009-05-25 2010-05-25 Sposoby diagnozowania lub prognozowania raka jelita grubego
US13/322,303 US20120101003A1 (en) 2009-05-25 2010-05-25 Methods for the diagnosis or prognosis of colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200930203A ES2361808B8 (es) 2009-05-25 2009-05-25 Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.

Publications (3)

Publication Number Publication Date
ES2361808A1 ES2361808A1 (es) 2011-06-22
ES2361808B1 ES2361808B1 (es) 2012-05-16
ES2361808B8 true ES2361808B8 (es) 2012-11-29

Family

ID=42542763

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200930203A Expired - Fee Related ES2361808B8 (es) 2009-05-25 2009-05-25 Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.
ES10730815.7T Active ES2551713T3 (es) 2009-05-25 2010-05-25 Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES10730815.7T Active ES2551713T3 (es) 2009-05-25 2010-05-25 Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal

Country Status (7)

Country Link
US (1) US20120101003A1 (es)
EP (1) EP2444811B1 (es)
AU (1) AU2010252907B2 (es)
CA (1) CA2763557C (es)
ES (2) ES2361808B8 (es)
PL (1) PL2444811T3 (es)
WO (1) WO2010136629A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014019781A1 (en) * 2012-07-30 2014-02-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
EP3094751A4 (en) * 2014-01-14 2017-06-07 Santa Maria Biotherapeutics, Inc. Activin inhibitor response prediction and uses for treatment
CN104777310A (zh) * 2015-01-23 2015-07-15 郑振海 一种肿瘤相关抗体定量检测试剂盒
ES2619116B1 (es) * 2015-12-23 2018-04-12 Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre Biomarcador para el diagnóstico, pronóstico y seguimiento de cáncer colorrectal de aparición precoz
CN110456069A (zh) * 2019-07-31 2019-11-15 四川大学华西医院 Zap70自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN110488014A (zh) * 2019-08-27 2019-11-22 成都和同易创生物科技有限公司 一种检测结直肠癌转移潜能的试剂盒及其使用方法
CN116670510A (zh) * 2020-10-05 2023-08-29 福瑞诺姆控股公司 用于结肠细胞增殖性病症的早期检测的标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275851A1 (en) * 2000-07-26 2006-12-07 Emmert-Buck Michael R Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples
US20030148314A1 (en) * 2001-08-01 2003-08-07 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
JP2008520228A (ja) * 2004-11-24 2008-06-19 セント ジョージズ エンタープライゼズ リミテッド 前立腺癌の診断
WO2006138275A2 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
WO2008061104A2 (en) * 2006-11-13 2008-05-22 Invitrogen Corporation Methods and kits for detecting prostate cancer biomarkers
JP2011528804A (ja) * 2008-07-18 2011-11-24 オラジェニックス，インコーポレイテッド 結腸直腸癌の検出及び治療のための組成物

Also Published As

Publication number Publication date
PL2444811T3 (pl) 2016-01-29
ES2551713T3 (es) 2015-11-23
WO2010136629A9 (es) 2011-01-20
WO2010136629A1 (es) 2010-12-02
ES2361808B1 (es) 2012-05-16
CA2763557C (en) 2019-04-23
EP2444811A1 (en) 2012-04-25
ES2361808A1 (es) 2011-06-22
CA2763557A1 (en) 2010-12-02
EP2444811B1 (en) 2015-08-05
AU2010252907A1 (en) 2012-01-12
AU2010252907B2 (en) 2016-03-17
US20120101003A1 (en) 2012-04-26

Similar Documents

Publication Publication Date Title
ES2644277T3 (es) Métodos de diagnóstico para determinar la prognosis del cáncer de pulmón de células no pequeñas
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
BR112014009643A2 (pt) métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal
IL254062B (en) Kits containing ptk7 antibody and their use in the treatment, detection, diagnosis or monitoring of cancer
WO2011095623A3 (en) miRNA IN THE DIAGNOSIS OF OVARIAN CANCER
WO2014160499A3 (en) Methods and compositions for detecting pancreatic cancer
EP2536854A4 (en) PERSONALIZED TUMOR BIOMARKERS
WO2010017515A3 (en) Breast cancer specific markers and methods of use
WO2012054638A3 (en) Nmr systems and methods for the detection of analytes
EP2534265A4 (en) SALIVARY BIOMARKERS FOR THE DETECTION OF LUNG CANCER
ZA201300519B (en) Novel antibody for the diagnosis and/or prognosis of cancer
BRPI1006075A2 (pt) biomarcadores de cancer
WO2014028884A3 (en) Cancer diagnostics using biomarkers
EP2625292A4 (en) KREBSBIOMARKER
PL2438445T3 (pl) Sposoby diagnozowania raków gruczołu krokowego
ES2361808B8 (es) Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.
HK1202313A1 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
WO2014078468A3 (en) Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent
GB2509682B (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
DK2451354T3 (da) Lancet
HK1220253A1 (zh) 诊断前列腺癌症的方法
SG11201508544VA (en) Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
SG2013065057A (en) Quantifying curvature of biological structures from imaging data
IT1398262B1 (it) Sonda ad ultrasuoni.

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 20110110

FG2A Definitive protection

Ref document number: 2361808

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20120516

FD2A Announcement of lapse in spain

Effective date: 20210915